Logo image of CBON

VANECK CHINA BOND ETF (CBON) Stock Overview

USA - NYSEARCA:CBON - US92189F3799 - ETF

22.425 USD
+0 (+0.02%)
Last: 9/16/2025, 6:35:00 PM
Fundamental Rating

6

CBON gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. Both the profitability and the financial health of CBON get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on CBON. CBON also has an excellent dividend rating. With these ratings, CBON could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CBON had positive earnings in the past year.
In the past year CBON had a positive cash flow from operations.
In the past 5 years CBON has always been profitable.
Each year in the past 5 years CBON had a positive operating cash flow.
CBON Yearly Net Income VS EBIT VS OCF VS FCFCBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.39%, CBON is in the better half of the industry, outperforming 76.25% of the companies in the same industry.
CBON has a Return On Equity of 8.81%. This is in the better half of the industry: CBON outperforms 73.75% of its industry peers.
CBON's Return On Invested Capital of 8.17% is fine compared to the rest of the industry. CBON outperforms 72.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBON is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
CBON Yearly ROA, ROE, ROICCBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CBON has a Profit Margin of 5.84%. This is in the better half of the industry: CBON outperforms 78.75% of its industry peers.
In the last couple of years the Profit Margin of CBON has remained more or less at the same level.
CBON has a better Operating Margin (10.65%) than 80.00% of its industry peers.
CBON's Operating Margin has been stable in the last couple of years.
CBON's Gross Margin of 27.60% is fine compared to the rest of the industry. CBON outperforms 72.50% of its industry peers.
CBON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
CBON Yearly Profit, Operating, Gross MarginsCBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CBON has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CBON has been reduced compared to 1 year ago.
CBON has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBON has a worse debt to assets ratio.
CBON Yearly Shares OutstandingCBON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CBON Yearly Total Debt VS Total AssetsCBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CBON has an Altman-Z score of 2.33. This is not the best score and indicates that CBON is in the grey zone with still only limited risk for bankruptcy at the moment.
CBON has a Altman-Z score of 2.33. This is comparable to the rest of the industry: CBON outperforms 42.50% of its industry peers.
CBON has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as CBON would need 6.05 years to pay back of all of its debts.
The Debt to FCF ratio of CBON (6.05) is better than 65.00% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that CBON is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.32, CBON is doing good in the industry, outperforming 67.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.33
ROIC/WACC1.28
WACC6.38%
CBON Yearly LT Debt VS Equity VS FCFCBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that CBON should not have too much problems paying its short term obligations.
CBON has a Current ratio (1.80) which is in line with its industry peers.
CBON has a Quick Ratio of 1.12. This is a normal value and indicates that CBON is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.12, CBON is in line with its industry, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
CBON Yearly Current Assets VS Current LiabilitesCBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

CBON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
CBON shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
CBON shows a decrease in Revenue. In the last year, the revenue decreased by -3.62%.
CBON shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

Based on estimates for the next years, CBON will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.31% on average per year.
Based on estimates for the next years, CBON will show a small growth in Revenue. The Revenue will grow by 2.56% on average per year.
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CBON Yearly Revenue VS EstimatesCBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
CBON Yearly EPS VS EstimatesCBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

CBON is valuated reasonably with a Price/Earnings ratio of 8.69.
Based on the Price/Earnings ratio, CBON is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
CBON is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
CBON is valuated cheaply with a Price/Forward Earnings ratio of 5.10.
86.25% of the companies in the same industry are more expensive than CBON, based on the Price/Forward Earnings ratio.
CBON's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 8.69
Fwd PE 5.1
CBON Price Earnings VS Forward Price EarningsCBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBON indicates a rather cheap valuation: CBON is cheaper than 86.25% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CBON is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.85
EV/EBITDA 3.52
CBON Per share dataCBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBON may justify a higher PE ratio.
CBON's earnings are expected to grow with 16.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)5.29
EPS Next 2Y19.47%
EPS Next 3Y16.31%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.38%, CBON is a good candidate for dividend investing.
CBON's Dividend Yield is a higher than the industry average which is at 3.89.
Compared to an average S&P500 Dividend Yield of 2.38, CBON pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.38%

5.2 History

On average, the dividend of CBON grows each year by 7.84%, which is quite nice.
CBON has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
CBON Yearly Dividends per shareCBON Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

CBON pays out 62.40% of its income as dividend. This is not a sustainable payout ratio.
CBON's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
CBON Yearly Income VS Free CF VS DividendCBON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
CBON Dividend Payout.CBON Dividend Payout, showing the Payout Ratio.CBON Dividend Payout.PayoutRetained Earnings

VANECK CHINA BOND ETF

NYSEARCA:CBON (9/16/2025, 6:35:00 PM)

22.425

+0 (+0.02%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners39.91%
Inst Owner Change-31.06%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.83B
Analysts80.87
Price Target26.96 (20.22%)
Short Float %0%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 4.38%
Yearly Dividend1.59
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-02 2025-09-02 (0.0299)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.36%
PT rev (3m)7.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.31%
EPS NY rev (3m)-9.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 8.69
Fwd PE 5.1
P/S 0.5
P/FCF 10.85
P/OCF 3.98
P/B 0.76
P/tB 1.03
EV/EBITDA 3.52
EPS(TTM)2.58
EY11.51%
EPS(NY)4.4
Fwd EY19.62%
FCF(TTM)2.07
FCFY9.22%
OCF(TTM)5.64
OCFY25.15%
SpS44.58
BVpS29.55
TBVpS21.75
PEG (NY)0.38
PEG (5Y)5.29
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.33
F-Score5
WACC6.38%
ROIC/WACC1.28
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%